SEC Form 4 · accession 0001209191-15-004679
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adelene Q Perkins
Officer — President & CEO · Director
Period of report
Jan 14, 2015
Accepted (ET)
Jan 16, 2015 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.74 | Jan 14, 2015 | A | 250,000 | A | — | Jan 14, 2025 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The option vests as to 1/48th of the shares on January 31, 2015 and vests as to 1/48th of the shares at the end of each calendar month thereafter.
Remarks
Exhibit 24 - Limited Power of Attorney